Related references
Note: Only part of the references are listed.A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
Faye A. Sharpley et al.
BLOOD CANCER JOURNAL (2019)
Identification of low level monoclonality using quantitative immunoprecipitation mass spectrometry (QIP-MS) as a first line monoclonal gammopathy screening strategy
R. Sadler et al.
CLINICA CHIMICA ACTA (2019)
Qip-Mass Spectrometry in High Risk Smoldering Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Residual Disease IMWG Response Assessment
Noemi Puig et al.
BLOOD (2019)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero et al.
LEUKEMIA (2017)
Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy
David R. Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Share Paper
